GebistorfF, KaramO, WetterslevJ, AfshariA. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev, 2016; 6:CD002787.
4.
RileyCM, MastropietroCW, SassalosP, BuckleyJR, CostelloJM, IliopoulosI, et al. Utilization of inhaled nitric oxide after surgical repair of truncus arteriosus: a multicenter analysis. Congenit Heart Dis, 2019; 14(6):1078–1086.
5.
WongJ, LoombaRS, EveyL, BronickiRA, FloresS. Postoperative inhaled nitric oxide does not decrease length of stay in pediatric cardiac surgery admissions. Pediatr Cardiol, 2019; 40(8):1559–1568.
6.
BearlDW, DoddDA, ThurmC, HallM, SoslowJH, FeingoldB, GodownJ. Practice variation, costs and outcomes associated with the use of inhaled nitric oxide in pediatric heart transplant recipients. Pediatr Cardiol, 2019; 40(3):650–657.
7.
BarringtonKJ, FinerN, PennaforteT, AltitG. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev, 2017; 1:CD00399.
8.
KollefMH, ShapiroSD, ClinkscaleD, CracchioloL, ClaytonD, WilnerR, HossinL. The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization. Chest, 2000; 117(2):467–475.
9.
StollerJK, MaschaEJ, KesterL, HaneyD. Randomized controlled trial of physician-directed versus respiratory therapy consult service directed respiratory care to adult non-ICU inpatients. Am J Respir Crit Care Med, 1998; 158(4):1068–1075.
10.
Todd TzanetosD, HousleyJJ, BarrFE, MayWL, LandersCD. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care, 2015; 60(5):644–650.
